Author details

Full Name

Juergen Graessler

Affiliation

ORCID

Career Start Year

1989

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36468334	Repeated lipoprotein apheresis and immune response: Effects on different immune cell populations.		2022
35413745	Precision Medicine Approach for Cardiometabolic Risk Factors in Therapeutic Apheresis.	Hormone and Metabolic Research	2022
35545115	Correction: Precision Medicine Approach for Cardiometabolic Risk Factors in Therapeutic Apheresis.	Hormone and Metabolic Research	2022
34356852	Classical Xanthinuria in Nine Israeli Families and Two Isolated Cases from Germany: Molecular, Biochemical and Population Genetics Aspects.	Biomedicines	2021
31818447	Short- and long-term effects of lipoprotein apheresis on plasma hormones in patients with therapy-resistant dyslipidemia.	Atherosclerosis Supplements	2019
28607507	Urinary Lipidomics: evidence for multiple sources and sexual dimorphism in healthy individuals.	Pharmacogenomics Journal	2018
29065430	Lipidomic Changes in Skeletal Muscle in Patients after Biliopancreatic Diversion.	Hormone and Metabolic Research	2017
28834964		Hormone and Metabolic Research	2017
29096826	Long-term follow-up of circulating oxidative stress markers in patients undergoing lipoprotein apheresis by Direct Adsorption of Lipids (DALI).	Atherosclerosis Supplements	2017
27736893	Detection of Independent Associations of Plasma Lipidomic Parameters with Insulin Sensitivity Indices Using Data Mining Methodology.	PLoS One	2016
25940301	Association between systemic oxidative stress and insulin resistance/sensitivity indices - the PREDIAS study.	Clinical Endocrinology	2016
27295977	Gender, Contraceptives and Individual Metabolic Predisposition Shape a Healthy Plasma Lipidome.	Sci Rep	2016
25936309	Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniques.	Atherosclerosis Supplements	2015
25782872	Quantitative profiling of endocannabinoids in lipoproteins by LC-MS/MS.	Anal Bioanal Chem	2015
25602349	Crosstalk Between Glycoxidative Modification of Low-Density Lipoprotein, Angiotensin II-Sensitization, and Adrenocortical Aldosterone Release.	Hormone and Metabolic Research	2015
25936322	Increasing plasma lysophosphatidylcholine levels in patients with regular dextran sulfate lipoprotein apheresis.	Atheroscler Suppl	2015
25236775	Lipidomic profiling at the interface of metabolic surgery and cardiovascular disease.	Current Atherosclerosis Reports	2014
24296717	Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity.	Diabetes	2014
24365785	Lipidomic profiling before and after Roux-en-Y gastric bypass in obese patients with diabetes.	Pharmacogenomics J	2014
23032991	Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters.	Pharmacogenomics Journal	2013
23852455	Stimulation of phagocyte adhesion to endothelial cells by modified VLDL and HDL requires scavenger receptor BI.	Molecular and Cellular Biochemistry	2013
23357158	Single whole blood dextran sulfate adsorption favorably affects systemic oxidative balance in lipoprotein apheresis patients.	Atherosclerosis Supplements	2013
23047828	Circulating very-low-density lipoprotein from subjects with impaired glucose tolerance accelerates adrenocortical cortisol and aldosterone synthesis.	Hormone and Metabolic Research	2013
22147656	Diabetic lipoproteins and adrenal aldosterone synthesis--a possible pathophysiological link?	Hormone and Metabolic Research	2012
22479202	Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.	PLoS Genet	2012
22382638	Modified high-density lipoprotein modulates aldosterone release through scavenger receptors via extra cellular signal-regulated kinase and Janus kinase-dependent pathways.	Molecular and Cellular Biochemistry	2012
22331364	Very-low-density lipoprotein mediates transcriptional regulation of aldosterone synthase in human adrenocortical cells through multiple signaling pathways.	Cell and Tissue Research	2012
22238593	A genome-wide association search for type 2 diabetes genes in African Americans.	PLoS One	2012
20551622	Type 2 diabetes in octogenarians is associated with decreased low molecular weight adiponectin.	Gerontology	2011
20185807	Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans.	Diabetes	2010
20858683	Common variants at 10 genomic loci influence hemoglobin Aâ¿(C) levels via glycemic and nonglycemic pathways.	Diabetes	2010
20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Nat Genet	2010
20081857	Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge.	Nat Genet	2010
20559286	Modulation of adrenal aldosterone release by oxidative modification of low-density lipoprotein.	American Journal of Hypertension	2010
18835979	Prediabetic and diabetic in vivo modification of circulating low-density lipoprotein attenuates its stimulatory effect on adrenal aldosterone and cortisol secretion.	Journal of Endocrinology	2009
19603071	Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients.	PLoS One	2009
20129371	Beyond lowering circulating LDL: apheresis-induced changes of systemic oxidative stress markers by four different techniques.	Atherosclerosis Supplements	2009
20129370	Acute effects of lipid apheresis on human serum lipidome.	Atherosclerosis Supplements	2009
18327257	SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.	Nat Genet	2008
18834627	Understanding deficient elimination of uric acid.	Lancet, The	2008
17992629	The dual substrate specificity of aldehyde oxidase 1 for retinal and acetaldehyde and its role in ABCA1 mediated efflux.	Hormone and Metabolic Research	2007
17380316	Glycoxidised LDL isolated from subjects with impaired glucose tolerance increases CD36 and peroxisome proliferator-activator receptor gamma gene expression in macrophages.	Diabetologia	2007
16837224	Association of the calpain-10 gene with type 2 diabetes in Europeans: results of pooled and meta-analyses.	Mol Genet Metab	2006
16673214	Gout--new insights into a forgotten disease.	Hormone and Metabolic Research	2006
16385546	Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population.		2006
16391483	[Intravenous oxygen therapy increases the activity of the antioxidative and antiatherogenic serum enzyme paraoxonase 1].		2005
16142856	Association of chondromodulin-II Val58Ile polymorphism with radiographic joint destruction in rheumatoid arthritis.	Journal of Rheumatology	2005
16132726	Hypochlorite-oxidized low-density lipoprotein upregulates CD36 and PPARgamma mRNA expression and modulates SR-BI gene expression in murine macrophages.	Molecular and Cellular Biochemistry	2005
15030176	The protective effects of HDL and its constituents against neutrophil respiratory burst activation by hypochlorite-oxidized LDL.	Molecular and Cellular Biochemistry	2004
14587078	Validation of different chemilumigenic substrates for detecting extracellular generation of reactive oxygen species by phagocytes and endothelial cells.	Luminescence	2003